Inventaire - twoi znajomi i społeczności to twoja najlepsza biblioteka

HPV-FASTER: broadening the scope for prevention of HPV-related cancer.

autor

Susanne Krüger Kjaer

1955 -

Silvia de Sanjosé

Claudia Robles

Laia Bruni

Mireia Díaz

Xavier Castellsagué

1959 - 2016

Jorge Salmerón

Joakim Dillner

1962 -

Suzanne Marie Garland

Chris J L M Meijer

Iacopo Baussano

Christine Clavel

Karl Ulrich Petry

Guglielmo Ronco

Jack Cuzick

1948 -

opublikowano w: Nature Reviews Clinical Oncology

data publikacji: 2015-09-01

język: język angielski

Cites articles 124

Data

Tytuł

Autorzy

2015-04-30

Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
2015-02-01

Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance

Nicolas Wentzensen, Mark Schiffman
2015-06-30

European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination

Silvia Franceschi, Joakim Dillner, Julietta Patnick
2015-01-01

Reliability of the Xpert HPV assay to detect high-risk human papillomavirus DNA in a colposcopy referral population

Kathleen M. Schmeler, Philip E. Castle
2015-05-01

Safety of human papillomavirus vaccines: a review

Pier Luigi Lopalco, Paloma Carrillo Santisteve
2015-02-11

Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States - 2008-2012.

Elizabeth R. Unger, Lauri E Markowitz, Nancy M Bennett, Linda M Niccolai, Susan Hariri, Martin Steinau, Sean Schafer, Mary W Scahill, Pamela J Julian, Nasreen Abdullah, Diane L Levine, Erin Whitney, HPV-IMPACT Working Group
2015-02-19

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

Suzanne Marie Garland, Jack Cuzick
2015-05

Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis

David Mesher, Clare Tanton, Kimberley Kavanagh, Pam Sonnenberg, Basil Donovan, Susanne Krüger Kjaer, Christopher K. Fairley, Marie-Claude Boily, Sepehr N Tabrizi, Julia M L Brotherton, Lauri E Markowitz, Linda M Niccolai, Jacques Brisson
2015-04-01

Value of quantitative and qualitative analyses of circulating cell-free DNA as diagnostic tools for hepatocellular carcinoma: a meta-analysis
2015-02-23

Organization and quality of HPV vaccination programs in Europe

Joakim Dillner
2015-01-12

Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial

Dan Apter, Frank Struyf, Jorma Paavonen
2015-02-19

Acceptability of human papillomavirus vaccines among women older than 26 years

Sarah E Brewer
2015-01-15

Distinct demographic factors influence the acceptance of vaccination against HPV.
2015-01-06

Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model

Mark Jit
2014-08-21

Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples

August Vidal, Michael Pawlita, Beatriz Quirós, Jorge Salmerón, Omar Clavero, Andrzej Nowakowski, Ignacio G Bravo
2014-05-30

Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide

Beatriz Quirós, Jorge Salmerón, Ana Felix, Omar Clavero, Jan Laco, Xavier Castellsagué, Ignacio G Bravo, Michael Pawlita, Robert Jach, Nubia Muñoz, Silvia de Sanjosé, Laia Alemany Perez, Isabel Alvarado-Cabrero, Hai-Rim Shin, Edyta C Pirog, Nuria Guimera, Belen Lloveras, Elena Kasamatsu, Marc T Goodman, Leopoldo Tinoco, Daan T Geraets, Christine Clavel, Cathy Ndiaye, Antonio L Cubilla, Brenda Y Hernandez
2014-07-03

50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence

Silvia Franceschi, Frank Bray, Stefan Lönnberg
2014-01-19

Cervical cancer screening: on the way to a shift from cytology to full molecular screening
2014-09

Guía de cribado del cáncer de cuello de útero en España, 2014
2014-11-06

Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data

Peter J F Snijders, Chris J L M Meijer
2014-10-22

A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results

Brian Befano, Henry A. Erlich
2014-02-13

Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial

Renske D. Steenbergen, Willem Melchers, Johan Bulten, Daniëlle A M Heideman, Chris J L M Meijer, Peter J F Snijders
2014-02-14

Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions

Janet Austin, Anne Szarewski, Jack Cuzick
2014-10-07

The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens

You-Lin Qiao, Wen-Ming Chen, Philip E. Castle
2014-01-14

Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis

Freija Verdoodt, Cristina Bellisario, Fanghui Zhao, Peter J F Snijders
2014-09-16

Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis

Neha Pathak, Javier Zamora, Khalid S Khan
2014-01-01

The Australian experience with the human papillomavirus vaccine

Suzanne Marie Garland
2014-02-19

Early impact of human papillomavirus vaccination on cervical neoplasia--nationwide follow-up of young Danish women

Christian Dehlendorff, Susanne Krüger Kjaer, Birgitte Baldur-Felskov
2014-10

Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study

S. Rachel Skinner, Deborah Bateson, Samuel Phillips, John Kaldor, Suzanne Marie Garland, Sepehr N Tabrizi, Julia M L Brotherton
2014-09-01

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

Anne Szarewski, S. Rachel Skinner, Suzanne Marie Garland, Wim Quint, Myron J Levin
2014-04-01

The road ahead for cervical cancer prevention and control

Ziad El-Khatib, Ziad El-Khatib, Eduardo L. Franco
2014-01-14

Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study

Alejandra Castanon, Rebecca Landy, Peter Sasieni, Jack Cuzick

Artykuł - wd:Q46902171

Witaj w Inventaire

biblioteka twoich znajomych i społeczności

dowiedz się więcej